Obesity Clinical Trials in Chicago

Showing 61-80 of 196 trials

DNA Methylation and Vascular Function

NCT03527420

The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.

ObesityVascular Dysfunction

University of Illinois at Chicago80 participantsStarted Oct 2019

Chicago, Illinois, United States

Active Not RecruitingPhase 32.2 miles

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

NCT05882045

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.

ObesityCardiovascular Diseases

Eli Lilly and Company1,800 participantsStarted May 2023

Phoenix, Arizona, United States • Covina, California, United States • Fresno, California, United States +166 more locations

DNA Methylation and Vascular Function

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Obesity Trials in Other Cities

Elements Vital to Treat Obesity Study

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption

Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human

Pediatric Obesity Weight Evaluation Registry (POWER) Study

Time Restricted Eating for the Treatment of PCOS

Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Long Term Extension Trial of Setmelanotide

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Other Conditions in Chicago